Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rachel M. Snyder
Observed names:
R Snyder,
R. M. Snyder
Institutions:
Boston University,
Van Andel Institute,
University of Pittsburgh,
Wayne State University,
Henry Ford Hospital,
The Barbara Ann Karmanos Cancer Institute,
Duke Medical Center
show all 7
Observed institutions:
Boston University,
Van Andel Institute,
University of Pittsburgh,
Baylor College of Medicine,
Wayne State University,
Henry Ford Hospital,
The Barbara Ann Karmanos Cancer Institute,
Duke Medical Center,
The University of Texas at Austin
show all 9
OpenAlex ID:
A5000233609
Novel vitamin E analogue and 9-nitro-camptothecin administered as liposome aerosols decrease syngeneic mouse mammary tumor burden and inhibit metastasis
2004
·
Karla A. Lawson
, Kristen Anderson
, et al.
·
Cancer Chemotherapy and Pharmacology
·
62
Aerosol Delivery of Liposomal Formulated Paclitaxel and Vitamin E Analog Reduces Murine Mammary Tumor Burden and Metastases
2009
·
Paul Latimer
, Marla Menchaca
, et al.
·
Experimental Biology and Medicine
·
47
Melphalan and Dexamethasone Plus Bortezomib Induces Hematologic and Organ Responses in AL-Amyloidosis with Tolerable Neurotoxicity.
2009
·
Jeffrey A Zonder
, Vaishali Sanchorawala
, et al.
·
Blood
·
21
Use of melphalan (M)/dexamethasone (D)/bortezomib in AL amyloidosis.
2010
·
C. Gasparetto
, V. Sanchorawala
, et al.
·
Journal of Clinical Oncology
·
17
Vitamin E Analog α -TEA, Methylseleninic Acid, andTrans-Resveratrol in Combination Synergistically Inhibit Human Breast Cancer Cell Growth
2008
·
Rachel M. Snyder
, Weiping Yu
, et al.
·
Nutrition and Cancer
·
9
Investigation of the effects of alpha-TEA, MSA and t-RES alone and in combination of human MDA-MB-435 breast cancer cells in vitro and in vivo
2006
·
Rachel M. Snyder
·
Texas ScholarWorks (Texas Digital Library)
·
2
PDF
A470 Phase II Trial of Mel/Dex + Bortezomib for AL Amyloidosis
2009
·
C Gasparetto
, JA Zonder
, et al.
·
Clinical Lymphoma & Myeloma
An exploratory feasibility study examining the addition of arsenic trioxide (ATO) and ascorbic acid (AA) to bortezomib, thalidomide, and dexamethasone (VTD) in the treatment of relapsed and refractory multiple myeloma
2008
·
J. N. Valent
, R. M. Snyder
, et al.
·
Journal of Clinical Oncology
α-TEA and 9-nitro-camptothecin alone and in combination, induces caspase dependent apoptosis in 66cl-4-GFP mouse mammary tumor cells in vitro and reduces mouse mammary tumor burden and metastases in vivo.
2007
·
Paul Latimer
, Rachel M. Snyder
, et al.
·
Molecular Cancer Therapeutics
Show more works
View as search
Works count:
9
Citation count:
158
H-index:
5
I10-index:
4
Year
Topic
Type